Drug Information

Drug General Information
Drug ID
D02TYC
Former ID
DNC000309
Drug Name
BetaARKct
Indication Discovery agent Investigative [535312]
Formula
C12H9NO6
Target and Pathway
Target(s) Beta-adrenergic receptor kinase 1 Target Info Inhibitor [535312]
KEGG Pathway Chemokine signaling pathway
Endocytosis
Glutamatergic synapse
Morphine addiction
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Parkinson disease
Angiotensin II-stimulated signaling through G proteins and beta-arrestin
Pathway Interaction Database Signaling events mediated by HDAC Class II
Thromboxane A2 receptor signaling
CXCR4-mediated signaling events
Signaling events mediated by the Hedgehog family
IL8- and CXCR1-mediated signaling events
Reactome Calmodulin induced events
G alpha (q) signalling events
Activation of SMO
WikiPathways Hedgehog Signaling Pathway
DAG and IP3 signaling
Gastrin-CREB signalling pathway via PKC and MAPK
Opioid Signalling
GPCR downstream signaling
References
Ref 535312Gene-mediated inhibition of the b-adrenergic receptor kinase: a new therapeutic strategy for heart failure. Minerva Cardioangiol. 2001 Dec;49(6):389-94.
Ref 535312Gene-mediated inhibition of the b-adrenergic receptor kinase: a new therapeutic strategy for heart failure. Minerva Cardioangiol. 2001 Dec;49(6):389-94.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.